FDA requires that an Investigational Review Board (IRB) must review all the documents related to the inclusion of participants within clinical trials. IRB is expected to review all the research documents and activities that bear directly on the rights and welfare of the subjects of proposed research. Specific for orphan conditions, this is the recruitment of patients with a rare disease that affects a small population of people.